Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-08-19
    E.g., 2018-08-19

Archive Search

1 results
12:00 AM, Aug 19, 2013  |  BioCentury | Emerging Company Profile

SynapDx: Autism early warning

controls. The company is testing an improved version of the gene expression signature, termed the SDX-002
data from about half of the patients will be used to refine the analysis of SDX-002
cohort of about 360 patients will be used to assess the sensitivity and concordance between SDX-002